Difference between revisions of "Vecuronium"

Vecuronium
	Clinical data
Drug class	Neuromuscular blocker
Routes of administration	Intravenous
	Dosage
	Vecuronium Standard; 0.1 mg/kg IV (Ideal body weight); Rapid sequence; 0.15-0.2 mg/kg IV (Ideal body weight); Maintenance (bolus); 0.01-0.015 mg/kg IV q20-40m (Ideal body weight); Maintenance (infusion); 0.05-0.07 mg/kg/hr IV (Ideal body weight); More information about this dose Weight kglbg Height cmminft Age yrmowk SexFM Indication Indication: Neuromuscular blockade Route Route: Intravenous For rapid sequence, can give priming dose of 0.01 mg/kg three minutes before induction to reduce onset of paralysis to 75 to 90 seconds. Ramzy M, McAllister RK. Vecuronium. [Updated 2021 Jul 25]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK493143/; Smith CE, Kovach B, Polk JD, Hagen JF, Fallon WF Jr. Prehospital tracheal intubating conditions during rapid sequence intubation: rocuronium versus vecuronium. Air Med J. 2002 Jan-Feb;21(1):26-32. doi: 10.1067/mmj.2002.121713. PMID: 11805764.; Baumgarten RK, Carter CE, Reynolds WJ, Brown JL, DeVera HV. Priming with nondepolarizing relaxants for rapid tracheal intubation: a double-blind evaluation. Can J Anaesth. 1988 Jan;35(1):5-11. doi: 10.1007/BF03010536. PMID: 2894903.; Ingrande J, Lemmens HJ. Dose adjustment of anaesthetics in the morbidly obese. Br J Anaesth. 2010 Dec;105 Suppl 1:i16-23. doi: 10.1093/bja/aeq312. PMID: 21148651.;
	Pharmacodynamics
Mechanism of action	Nicotinic acetylcholine antagonism
	Pharmacokinetics
	Physical and chemical data
	Article quality
Editor rating	Unrated
User likes	0

Revision as of 00:33, 30 March 2022

Provide a brief summary of this drug here.

Uses

Contraindications

Absolute contraindications

Precautions

Pharmacology

Pharmacodynamics

Mechanism of action

Adverse effects

Pharmacokinetics

Chemistry and formulation

History

References

Top contributors: Cornel Chiu and Chris Rishel

@@ Line 1: / Line 1: @@
 {{Infobox drug reference
 | trade_names =
-| drug_class =Neuromuscular blocker
+| drug_class = Neuromuscular blocker
-| drug_class_color =neuromuscular_blocker
+| drug_class_color = neuromuscular_blocker
 | uses =
 | contraindications =
-| routes =Intravenous
+| routes = Intravenous
 | dosage =
-|halflife_redistribution=|protein_binding=|clearance=|halflife_elimination=|adverse_effects=|metabolism=|duration=|time_onset=|mechanism=Nicotinic acetylcholine antagonism|image_file=Vecuronium.svg}}
+| halflife_redistribution =
+| protein_binding =
+| clearance =
+| halflife_elimination =
+| adverse_effects =
+| metabolism =
+| duration =
+| time_onset =
+| dosage_calculation = vecuronium
+| mechanism = Nicotinic acetylcholine antagonism
+| image_file = Vecuronium.svg
+}}
 Provide a brief summary of this drug here.